CAI (Caris Life Sciences, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Caris Life Sciences, Inc. Common Stock (CAI) is a publicly traded Healthcare sector company. As of May 21, 2026, CAI trades at $15.73 with a market cap of $4.27B and a P/E ratio of -2.47. CAI moved +4.88% today. Year to date, CAI is -40.55%; over the trailing twelve months it is flat. Its 52-week range spans $14.19 to $42.50. Analyst consensus is strong buy with an average price target of $27.92. Rallies surfaces CAI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns CAI stock?

Hedge funds tracked by Rallies that own CAI include Coatue Management, Orbimed Advisors, Duquesne Family, Soros Fund, and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Caris Life Sciences, Inc. Common Stock.

CAI Key Metrics

Key financial metrics for CAI
MetricValue
Price$15.73
Market Cap$4.27B
P/E Ratio-2.47
EPS$-6.27
Dividend Yield0.30%
52-Week High$42.50
52-Week Low$14.19
Volume2.50M
Avg Volume0
Revenue (TTM)$907.29M
Net Income$33.98M
Gross Margin0.00%

Top Hedge Funds Holding CAI

  • Coatue Management holds 9.82M shares of CAI, changed -50.00% as of Mar 31, 2026.
  • Orbimed Advisors holds 2.81M shares of CAI, changed -9.92% as of Mar 31, 2026.
  • Duquesne Family holds 1.89M shares of CAI, changed +0.00% as of Mar 31, 2026.
  • Soros Fund holds 55.65K shares of CAI, changed +11.30% as of Sep 30, 2025.
  • Mangrove Partners holds 42.48K shares of CAI, changed +0.00% as of Dec 31, 2025.

Latest CAI News

Recent CAI Insider Trades

  • Vacirca Jeff L bought 31.05K (~$501.43K) on May 11, 2026.
  • Power Luke Thomas sold 60.85K (~$1.62M) on Dec 11, 2025.
  • Power Luke Thomas sold 1.40K (~$38.02K) on Dec 11, 2025.

CAI Analyst Consensus

12 analysts cover CAI: 0 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $27.92.

Common questions about CAI

Who owns CAI stock?
Hedge funds tracked by Rallies that own CAI include Coatue Management, Orbimed Advisors, Duquesne Family, Soros Fund, and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Caris Life Sciences, Inc. Common Stock.
Does Rallies show 13F holders for CAI?
Yes. Rallies tracks hedge fund and 13F ownership data for CAI, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CAI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CAI. It does not provide personalized investment advice.
CAI

CAI